The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejectionAlexandre Loupy, Michael Mengel, Mark Haas et al.|American Journal of Transplantation|2020Cited by 809
The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnosticsMaarten Naesens, Michael Mengel, Candice Roufosse et al.|American Journal of Transplantation|2023Cited by 254
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated RejectionKatharina A. Mayer, Georg A. Böhmig, Uptal D. Patel et al.|New England Journal of Medicine|2024Cited by 151
The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allograftsCandice Roufosse, Chris Wiebe, Maarten Naesens et al.|American Journal of Transplantation|2023Cited by 49
Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammationMatthias Diebold, Georg A. Böhmig, Hannes Vietzen et al.|American Journal of Transplantation|2023Cited by 26